CDK2-IN-21

• Description :

  CDK2-IN-21 (example 30) is a potent cyclin-dependent kinase 2 (CDK2) inhibitor with an IC50 of 0.24 µM. CDK2-IN-21 can be used for cancer research[1].

• UNSPSC :

  12352005

• Target :

  CDK

• Related Pathways :

  Cell Cycle/DNA Damage

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Smiles :

  FC(F)(C12CC(C2)(C3=NC(C4=C(C(NS(=O)(C5=C(C=CC=C5F)C(F)(F)F)=O)=CC=C4)F)=C(C6=NC(N[C@@H]7CC[C@H](CC7)S(C)(=O)=O)=NC=C6)S3)C1)F

• Molecular Formula :

  C33H29F8N5O4S3

• Molecular Weight :

  807.80

• References & Citations :

  [1]Yan Lou. Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors. US20230303509. 2025-06-17.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  CDK2

• CAS Number :

  [2991229-06-0]